{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:34Z","timestamp":1753891894476,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>A 2-month-old male infant presented with white colored stools 1 month after birth. There was no jaundice of the skin, mucous membrane, or sclera; his liver was enlarged (4 cm below the ribs), and his liver function tests showed slightly elevated total bilirubin (TB), direct bilirubin (DB), and total bile acid (TBA). An abdominal doppler ultrasound showed no signs of biliary atresia. Genetic testing revealed a <jats:italic>CFTR<\/jats:italic> hemizygous mutation site (c.223C&amp;gt;T) in exon 3 and exon 2\u20133 heterozygous deletion mutation. The infant's stool turned yellow after oral administration of pancreatic tablets. Finally, the infant was diagnosed with cystic fibrosis (CF). Review of literature revealed five children (including the infant in this case study) with CF who presented with white stool. All five children had anemia, four had edema and hypoproteinemia, five had changes in stool color (it was pistachio-green color in two patients, pale colored in one, acholic stool in one, and white stool in one), two had cholestasis, one infant had delayed meconium discharge, and three children had delayed growth and hepatomegaly. Two children had an abnormal sweat test, one had a F508del compound heterozygous mutation, and one had three mutation sites (C.214G&amp;gt;G\/A, P.A72T; C.650A&amp;gt;A\/G, P.E217G, and C.3406G&amp;gt;G\/A, P. A1136T), which was a compound heterozygous mutation. So, CF could be included in the differential diagnosis of infants with white stool. Genetic testing could confirm an early diagnosis of CF. Pancreatic replacement therapy has been shown to be beneficial for improving the digestive function.<\/jats:p>","DOI":"10.3389\/fped.2021.656584","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:21:54Z","timestamp":1618381314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: White Colored Stool: An Early Sign of Cystic Fibrosis in Infants"],"prefix":"10.3389","volume":"9","author":[{"given":"Jing","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-qin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/TACG.S78241","article-title":"Analysis of the CFTR gene in Venezuelan cystic fibrosis patients, identification of six novel cystic fibrosis-causing genetic variants","volume":"9","author":"S\u00e1nchez","year":"2016","journal-title":"Appl Clin Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jcf.2015.09.008","article-title":"Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment","volume":"15","author":"VanDevanter","year":"2016","journal-title":"J Cyst Fibros"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.lpm.2017.05.011","article-title":"Current and emerging comorbidities in cystic fibrosis","volume":"46","author":"Ronan","year":"2017","journal-title":"Presse Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/resp.12656","article-title":"Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments","volume":"20","author":"Singh","year":"2015","journal-title":"Respirology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-020-01393-w","article-title":"Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis","volume":"15","author":"Liu","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1499-3872(13)60065-X","article-title":"The diagnostic value of high-frequency ultrasonography in biliary atresia","volume":"12","author":"Jiang","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/humu.9281","article-title":"Indentification of novel and rare mutation in California Hispanic and African American cystic fibrosis patients","volume":"24","author":"Alper","year":"2004","journal-title":"Hum Mutat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3760\/cma.j.issn.0578-1310.2016.11.013","article-title":"Infantile cholestasis caused by CFTR mutation: case report and literature review","volume":"54","author":"Li","year":"2016","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13312-020-1788-8","article-title":"An infants with severe anemia and hypoalbuminemia","volume":"57","author":"Kumar","year":"2020","journal-title":"Indian Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/S0140-6736(05)63730-0","article-title":"Pistachio-green stools and anaemia in infancy: early signs of cystic fibrosis?","volume":"349","author":"Jakobson","year":"1997","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcf.2014.01.007","article-title":"Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis","volume":"13","author":"Terlizzi","year":"2014","journal-title":"J Cyst Fibros"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"key":"B14","first-page":"127","article-title":"Novel therapeutic approaches for cystic fibrosis","volume":"15","author":"Wilschanski","year":"2013","journal-title":"Discov Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jpeds.2014.01.022","article-title":"Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis","volume":"164","author":"Haupt","year":"2014","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/MPG.0000000000001829","article-title":"Pancreatic enzyme replacement therapy use in infants with cystic fibrosis diagnosed by newborn screening","volume":"66","author":"Gelfond","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4081\/mrm.2020.690","article-title":"Novel therapeutic approaches for the management of cystic fibrosis","volume":"15","author":"Jaques","year":"2020","journal-title":"Multidiscip Respir Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s40265-019-01233-7","article-title":"Elexacaftor\/Ivacaftor\/Tezacaftor: first approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.656584\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:21:56Z","timestamp":1618381316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.656584\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":18,"alternative-id":["10.3389\/fped.2021.656584"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.656584","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"article-number":"656584"}}